Table 1.
Clinicopathological characteristics of the study population (n = 327)
| Characteristics | Value |
|---|---|
| Age, years, |
|
| mean ± SD |
47.79 ± 11.03 |
| range |
|
| ≥45 |
210 (64.2%) |
| <45 |
117 (35.8%) |
| Sex, |
|
| male |
59 (18%) |
| female |
268 (82%) |
| Tumour size, cm, |
|
| mean ± SD |
1.04 ± 0.73 |
| ≤1 cm |
213 (65.1%) |
| >1 cm |
114 (34.9%) |
| Extrathyroidal extension |
192 (58.7%) |
| BRAFV600E mutation |
241 (73.7%) |
| Lymph node metastasis |
147 (45%) |
| Central node metastasis |
145 (44.3%) |
| Lateral node metastasis |
28 (8.6%) |
| TNM stage |
|
| I |
137 (41.9%) |
| II |
40 (12.2%) |
| III |
121 (37.0%) |
| IVA |
18 (8.9%) |
| Extent of surgery |
|
| Total thyroidectomy |
270 (82.6%) |
| Hemithyroidectomy |
55 (16.8%) |
| Completion thyroidectomy |
2 (0.6%) |
| Hashimoto thyroiditis | 56 (17.1%) |
Results are presented as mean ± SD, or number of patients (%). TNM, classification by tumour, nodes and metastases.